Objectives To determine the time interval between mifepristone and misoprostol
administration associated with the most efficacious early pregnancy loss (EPL) …

Background Early pregnancy loss is a common event in the first trimester, occurring in 15%–
20% of confirmed pregnancies. A common evidence-based medical regimen for early …

Background Medical management of early pregnancy loss is an alternative to uterine
aspiration, but standard medical treatment with misoprostol commonly results in treatment …

Mifepristone was recently approved in the United States. Regimens with shorter intervals
may be more acceptable. The objective of this study was to determine whether the oral route …

In this prospective randomized parallel group study, subjects with a pregnancy of less than
63 d were randomized to receive either (i) 200 mg oral mifepristone plus 400 μg misoprostol …

Objectives To compare the efficacy of two different regimens of mifepristone followed by
misoprostol for medical abortion in women with menstrual delay of≤ 35 days. Design …

Objective To compare the efficacy of 100 mg and 200 mg of mifepristone and 24‐and 48‐
hour intervals to administration of 800μg vaginal misoprostol for termination of early …

Background Worldwide, millions of women seek treatment for early pregnancy loss (EPL)
annually. Medical management with misoprostol is widely used, but only effective 60% of the …

BACKGROUND: In an attempt to improve efficacy for women who desire medical
management of early pregnancy failure (EPF), we studied the efficacy and acceptability of …

Objective To compare time from misoprostol initiation to fetal expulsion for mifepristone–
misoprostol versus misoprostol-alone regimens of medication abortion performed at≥ 24 …